| Financial Year |
March 31 2023 |
| Monetary Funds |
247,657,348.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
95,099,841.45 |
| Accounts Receivable |
564,982,761.79 |
| Advances to Suppliers |
137,028,960.61 |
| Other Receivables |
177,164,770.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
27,481,454.00 |
| Inventories |
208,281,281.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,287,684.22 |
| Total Current Assets |
1,559,251,679.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
418,081,604.81 |
| Investment Properties |
224,298,974.79 |
| Fixed Assetes |
606,001,988.06 |
| Under-construction Projects |
277,710,692.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,641,626.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,495,638.21 |
| Deferred Income Tax Assets |
7,900,420.03 |
| Other Non-Current Assets |
87,821,424.36 |
| Sub-Total of Non-Current Assets |
1,917,352,369.68 |
| Total Assets |
3,476,604,049.46 |
| Short-Term Loans |
495,822,563.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,000,000.00 |
| Accounts Payable |
1,000,507,849.68 |
| Accounts Received In Advance |
11,707,511.88 |
| Employee Compensation Payable |
7,406,805.01 |
| Taxes Payable |
1,631,415.90 |
| Interest Payable |
16,599,268.15 |
| Dividend Payable |
-- |
| Other payables |
281,772,775.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,655,199.40 |
| Other Current Liabilities |
115,865,343.30 |
| Sub-Total of Current Liabilities |
2,111,324,857.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
504,999,338.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
993,321,223.03 |
| Deferred Income Tax Liabilities |
4,857,762.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,520,160,915.40 |
| Total Liabilities |
3,631,485,772.54 |
| Paid-In Capital(Or Share Stock) |
759,903,511.00 |
| Capital Surplus |
2,867,282,478.54 |
| Surplus Reserve |
43,458,367.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,875,087,946.74 |
| Minority Stockholder's Interest |
49,561,866.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-204,443,589.27 |
| Owner's Equity（Stockholder's Equity） |
-154,881,723.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,476,604,049.46 |
